216 related articles for article (PubMed ID: 9331009)
41. Effects and tolerability of irbesartan versus enalapril in patients with severe hypertension. Irbesartan Multicenter Investigators.
Larochelle P; Flack JM; Marbury TC; Sareli P; Krieger EM; Reeves RA
Am J Cardiol; 1997 Dec; 80(12):1613-5. PubMed ID: 9416950
[TBL] [Abstract][Full Text] [Related]
42. Angiotensin receptor antagonists.
Wong W; Howes L
Aust Fam Physician; 2000 Jul; 29(7):653-5, 658. PubMed ID: 10914449
[TBL] [Abstract][Full Text] [Related]
43. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in African-American patients with hypertension.
Papademetriou V; Narayan P; Kokkinos P
J Clin Hypertens (Greenwich); 2004 Jun; 6(6):310-4. PubMed ID: 15187493
[TBL] [Abstract][Full Text] [Related]
44. Pharmacokinetics of candesartan cilexetil in patients with renal or hepatic impairment.
de Zeeuw D; Remuzzi G; Kirch W
J Hum Hypertens; 1997 Sep; 11 Suppl 2():S37-42. PubMed ID: 9331004
[TBL] [Abstract][Full Text] [Related]
45. Candesartan cilexetil. A review of its use in essential hypertension.
McClellan KJ; Goa KL
Drugs; 1998 Nov; 56(5):847-69. PubMed ID: 9829158
[TBL] [Abstract][Full Text] [Related]
46. Improving prognosis in hypertension: exploring the benefits of angiotensin II type 1 receptor blockade.
Ruilope L
Blood Press Suppl; 2000; 1():31-5. PubMed ID: 11059634
[TBL] [Abstract][Full Text] [Related]
47. Reducing cardiovascular morbidity and mortality in the elderly.
Trenkwalder P
Blood Press Suppl; 2000; 1():40-3. PubMed ID: 11059636
[TBL] [Abstract][Full Text] [Related]
48. Efficacy and tolerability of candesartan cilexetil vs. amlodipine as assessed by home blood pressure in hypertensive patients.
Imbs JL; Nisse-Durgeat S;
Int J Clin Pract; 2005 Jan; 59(1):78-84. PubMed ID: 15707470
[TBL] [Abstract][Full Text] [Related]
49. Antiproteinuric effect of candesartan cilexetil in patients with chronic glomerulonephritis.
Kurokawa K; Abe K; Saruta T; Arakawa M; Kikkawa R; Ueda N; Onoyama K; Tomita K; Ogawa N
J Renin Angiotensin Aldosterone Syst; 2002 Sep; 3(3):167-75. PubMed ID: 12563567
[TBL] [Abstract][Full Text] [Related]
50. Tolerability of a modern antihypertensive agent: candesartan cilexetil.
Andersson OK
Basic Res Cardiol; 1998; 93 Suppl 2():54-8. PubMed ID: 9833164
[TBL] [Abstract][Full Text] [Related]
51. Candesartan cilexetil effectively reduces blood pressure in hypertensive children.
Franks AM; O'Brien CE; Stowe CD; Wells TG; Gardner SF
Ann Pharmacother; 2008 Oct; 42(10):1388-95. PubMed ID: 18664605
[TBL] [Abstract][Full Text] [Related]
52. Randomized trial of candesartan cilexetil in the treatment of patients with congestive heart failure and a history of intolerance to angiotensin-converting enzyme inhibitors.
Granger CB; Ertl G; Kuch J; Maggioni AP; McMurray J; Rouleau JL; Stevenson LW; Swedberg K; Young J; Yusuf S; Califf RM; Bart BA; Held P; Michelson EL; Sellers MA; Ohlin G; Sparapani R; Pfeffer MA
Am Heart J; 2000 Apr; 139(4):609-17. PubMed ID: 10740141
[TBL] [Abstract][Full Text] [Related]
53. Treatment of hypertension with an angiotensin II-receptor antagonist compared with an angiotensin-converting enzyme inhibitor: a review of clinical studies of telmisartan and enalapril.
Smith DH
Clin Ther; 2002 Oct; 24(10):1484-501. PubMed ID: 12462282
[TBL] [Abstract][Full Text] [Related]
54. Comparison of the effects of candesartan cilexetil and enalapril maleate on right ventricular myocardial remodeling in dogs with experimentally induced pulmonary stenosis.
Yamane T; Fujii Y; Orito K; Osamura K; Kanai T; Wakao Y
Am J Vet Res; 2008 Dec; 69(12):1574-9. PubMed ID: 19046003
[TBL] [Abstract][Full Text] [Related]
55. Angiotensin receptor antagonists.
Goldsmith DJ
Lancet; 1997 Apr; 349(9060):1255. PubMed ID: 9130973
[No Abstract] [Full Text] [Related]
56. Candesartan for hypertension.
Med Lett Drugs Ther; 1998 Nov; 40(1040):109-10. PubMed ID: 9844624
[No Abstract] [Full Text] [Related]
57. Irbesartan treatment in hypertension.
Brown MJ
Hosp Med; 1998 Oct; 59(10):808-11. PubMed ID: 9850301
[TBL] [Abstract][Full Text] [Related]
58. [Comparison with other antihypertensive drugs, especially with ACEI].
Hiwada K
Nihon Rinsho; 1999 May; 57(5):1187-93. PubMed ID: 10361454
[TBL] [Abstract][Full Text] [Related]
59. Effects of antihypertensive treatment on ultrasound measures of myocardial fibrosis in hypertensive patients with left ventricular hypertrophy: results of a randomized trial comparing the angiotensin receptor antagonist, candesartan and the angiotensin-converting enzyme inhibitor, enalapril.
Ciulla MM; Paliotti R; Esposito A; Cuspidi C; Muiesan ML; Rosei EA; Magrini F; Zanchetti A
J Hypertens; 2009 Mar; 27(3):626-32. PubMed ID: 19262230
[TBL] [Abstract][Full Text] [Related]
60. Long-term treatment with candesartan cilexetil does not affect glucose homeostasis or serum lipid profile in mild hypertensives with type II diabetes.
Trenkwalder P; Lehtovirta M; Dahl K
J Hum Hypertens; 1997 Sep; 11 Suppl 2():S81-3. PubMed ID: 9331016
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
